首页|免疫失衡在腹泻型肠易激综合征发病中的机制及中药干预研究进展

免疫失衡在腹泻型肠易激综合征发病中的机制及中药干预研究进展

Research Progress on the Mechanism of Immune Imbalance in the Pathogenesis of IBS-D and Chinese Medicine Intervention

扫码查看
原文链接
  • 国家科技期刊平台
  • NETL
  • NSTL
  • 万方数据
腹泻型肠易激综合征(IBS-D)是一种临床常见的功能性胃肠病,免疫失衡在其发病中起重要作用.相关免疫细胞包括固有免疫细胞和适应性免疫细胞,免疫细胞因子包括免疫球蛋白、干扰素、白介素、肿瘤坏死因子等.中药单体/化合物或复方可通过多通路、多靶点调节免疫治疗IBS-D.本文从免疫失衡与肠道感染、菌群失调、脑肠轴紊乱、内分泌紊乱的关系等方面,对中药单体/化合物和复方靶向免疫治疗IBS-D的相关文献进行了系统回顾与梳理,并同时印证了"脾为之卫"与免疫相通之处,以期为中医药通过免疫介导途径治疗IBS-D及相关疾病提供思路.
Diarrhea-predominant irritable bowel syndrome(IBS-D)is a clinically common functional gastrointestinal disease,in which immune imbalance plays an important role.Related immune cells include innate immune cells and adaptive immune cells,and immune cytokines include immunoglobulin,interferon,interleukin,tumor necrosis factor,etc.Traditional Chinese medicine monomers/compounds or compound formulas can regulate immunotherapy for IBS-D through multi-pathway,multi-target.This article systematically reviews and sorts out relevant literature on targeted immunotherapy of IBS-D using traditional Chinese medicine monomers/compounds and compound therapies from the perspectives of immune imbalance and intestinal infection,dysbiosis of flora,brain-gut axis disorder,and endocrine disorders.At the same time,it confirms the similarities between the"spleen as the guard"and immunity,to provide ideas for traditional Chinese medicine to treat IBS-D and related diseases through immune-mediated pathways.

Diarrhea-predominant irritable bowel syndromeImmune imbalanceChinese medicine compoundTraditional Chinese medicine monomers/compoundsResearch progress

梅笑、潘海迪、吴晓睿、贺昌辉、窦鑫、邓华亮、王伟

展开 >

250014 山东省济南市,山东中医药大学第一临床医学院

250014 山东省济南市,山东中医药大学中医学院

250014 山东省济南市,山东中医药大学附属医院消化内二科

腹泻型肠易激综合征 免疫失衡 中药复方 中药单体/化合物 研究进展

国家自然科学基金青年基金山东省中医药重点学科中医脾胃病学项目山东省中医药科技面上项目国家中医药局科技司共建科技项目

81904128鲁卫中医药科教字[2022]4号M-2023167GZY-KJS-SD-2023-035

2024

10.12114/j.issn.1007-9572.2023.0835

中国全科医学
中国医院协会

中国全科医学

CSTPCD北大核心
影响因子：2.04
ISSN：1007-9572
年,卷(期)：2024.27(35)